Dorsey Wright & Associates Nuvectis Pharma, Inc. Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$12.89 - $16.29 $618 - $781
-48 Reduced 3.32%
1,396 $17,000
Q2 2023

Jul 26, 2023
BUY
$12.62 - $18.4 $18,223 - $26,569
1,444 New
1,444 $23,000

Others Institutions Holding NVCT

# of Institutions
32
Shares Held
1.65M
Call Options Held
0
Put Options Held
0
View Full List

About Nuvectis Pharma, Inc.

NVCT Quotes by TradingView
  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $68.8M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email